Gary Dahl
Academic Appointments
- Professor - Med Center Line, Pediatrics - Hematology & Oncology
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Pediatric Hematology-Oncology 725 Welch Rd MC 5798 Palo Alto, CA 94034 Tel Work (650) 497-8953 Fax (650) 497-8959Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5114 Tel (650) 723-5535Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pediatric Hematology-Oncology
- Ped Hematology/Oncology
Professional Education
| Internship: | University of Oregon OR (1968) |
| Residency: | University of Oregon OR (1974) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1976) |
| Board Certification: | Pediatric Hematology-Oncology, American Board of Pediatrics (1976) |
| Fellowship: | St. Jude Children's Research Hospital TN (1976) |
| Medical Education: | University of Oregon Medical School OR (1967) |
Scientific Focus
Current Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
Clinical Trials
- Not Recruiting Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
- Not Recruiting Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
- Recruiting Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
- Not Recruiting T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
- Not Recruiting A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Publications
- Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia. 2013; (3): 731-4
- Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol. 2012; (29): 3625-32
- Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. J Neurooncol. 2012; (2): 287-91
- Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood. 2012; (22): 4407-17
- Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis. Pediatr Blood Cancer. 2012; (1): 101-3
- Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics. 2010; (5): e1241-5
Help
Trial Administration